Qube Research & Technologies (QRT)
SION icon

Qube Research & Technologies (QRT)’s Sionna Therapeutics SION Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-140,309
Closed -$6.17M – 4243
2026
Q2 		$6.17M Buy
140,309
+98,067
+232% +$3.92M 0.01% 1532
2026
Q1 		$1.69M Buy
+42,242
New +$1.61M ﹤0.01% 2263

Other funds holding SION

Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $109B AUM 29.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SION Position: Q3 2026 in Review

Qube Research & Technologies (QRT) sold out of Sionna Therapeutics (SION) in Q3 2026, closing a stake of 140,309 shares — an estimated $6.17M sold.

Qube Research & Technologies (QRT) first reported a position in SION in Q1 2026 and held it in 2 quarters. The position peaked at $6.17M in Q2 2026. 87 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • Qube Research & Technologies (QRT) reported no remaining Sionna Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 140,309 Sionna Therapeutics shares in Q3 2026, an estimated $6.17M.
  • Qube Research & Technologies (QRT) first reported a position in Sionna Therapeutics in Q1 2026 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Sionna Therapeutics position peaked at $6.17M in Q2 2026.
  • 87 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.